Taxpayers may struggle to challenge SARS’s authority to repatriate foreign assets after a High Court ruling upheld its powers, potentially paving the way for more assertive tax enforcement.
Despite a 20-year debarment, a R143m fine, and even losing a leg in a motorcycle accident, Cobus Geldenhuis is allegedly still defrauding investors under a new alias.
Financial planners weigh in on the fallout and why investors should stay calm.
A PA-commissioned solvency report questions Ithala’s financial health, raising concerns about its equity, loan book, and potential shortfall in repaying depositors.
The arrest of two more former Steinhoff executives ties back to a fraudulent scheme involving a handwritten note by Markus Jooste.
The Department of Basic Education has filed a review application, aiming to have the notice barring the publication of the matric results declared unconstitutional.
Authorities have convicted six individuals in the VBS Mutual Bank fraud case, including former executives and municipal officials. However, with 29 accused still on trial and 43 more suspects under investigation, the case is far from over.
PSG Asset Management warns that market complacency, overconcentration in US equities, challenging starting valuations, and potential policy risks could make the next decade challenging for investors.
The increase in certified professionals reflects both a growing recognition of the value of financial planners and a shift towards more inclusive, client-focused financial advice.
Treasury and SASSA respond to an allegation that Ithala’s client database was ‘unlawfully’ transferred to FNB.
Ithala accuses the appointed repayment administrator of overstepping his authority, while the Prudential Authority moves to liquidate the entity.
Scammers are preying on Banxso investors, promising to recover lost funds for a fee, the FSCA warns.
As insurers increasingly turn to alternative assets and cross-border reinsurance, industry experts highlight the growing complexities and risks.
The stokvel misused a significant portion of the money it collected, while the remaining amounts were used to pay purported returns to some investors, says the Authority.
The demand for GLP-1 medications as a weight-loss solution raises critical questions about accessibility, affordability, and the long-term sustainability of their use for managing obesity and diabetes.
After years of meticulous development, the International Association of Insurance Supervisors is shifting its focus to the next big challenge: rolling out the Insurance Capital Standard on a global scale.
Aon’s 2025 Global Medical Trend Rates Report points to a concerning widening gap between medical inflation and general inflation.
Notifications
